Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma (Q80829557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

title

Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

author name string

G Corona

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

E Vaccher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

S Sandron

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

I Sartor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

U Tirelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

F Innocenti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

publication date

22 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

601-606

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

Epidemiology of AIDS-related tumours in developed and developing countries

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Twenty years of therapy for HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

HIV-Protease Inhibitors

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Interactions of HIV protease inhibitors with ATP-dependent drug export proteins

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Drug interactions between antiretroviral drugs and comedicated agents

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Interactions between antiretrovirals and antineoplastic drug therapy.

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Pharmacokinetic enhancement of protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Lopinavir/ritonavir: a review of its use in the management of HIV infection

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Irinotecan in the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Evidence of activity of Irinotecan in patients with advanced AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Modulation of irinotecan metabolism by ketoconazole

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833.

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Mechanism of indinavir-induced hyperbilirubinemia

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038/SJ.CLPT.6100330

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17713471 AND SRC:MED&resulttype=core&format=json

3 January 2020

1 reference